MAR-METHIMAZOLE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 173aa88ffb1feb55
Drug Approval Canada Name: MAR-METHIMAZOLE
Product Name: MAR-METHIMAZOLE
Status: Marketed
Status Date: 2018-10-19
Original Market Date: 2018-10-19
Din: 02480107
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:36.08
Atc Original: H03BB02 THIAMAZOLE
Atc Name: h 03 bb 02
Aig Number: 0104552001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

METHIMAZOLE

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

173aa88ffb1feb55

Type

Standard